New ways to care Pierre Fabre Group held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale …

Sectors: Pharmaceutical

[Automatic translation follows] For safe, effective, innovative and accessible health products The National Agency for the Safety of Medicines and Health Products is the public actor which allows, on behalf of the State, access to health products in France and which ensures their safety throughout their life cycle. . At the heart of the health system, we act in the service of patients and their safety. We promote access to innovative products via authorization procedures adapted to each stage of the drug's life before and after its marketing. Through our evaluations, our expertise and our surveillance policy, we ensure that …

[Automatic translation follows] General interest insurer KLESIA is a social protection group. Our main businesses: supplementary health insurance, mutual insurance, supplementary retirement and insurance. A joint non-profit group, we have no shareholders to pay. KLESIA is made up of entities represented by employers and employees who guide the Group's strategy and make decisions to best defend the interests of customers. Joining us means participating in large-scale projects of general interest serving 300,000 companies, 4.7 million people covered by personal insurance and 2.1 million retirees. KLESIA affirms every day its desire to be a socially responsible General Interest insurer within a …

Sectors: Insurance

Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using …

Sectors: Biotechnology Pharmaceutical